Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -41.04 | 47.84 |
PEG Ratio (TTM) | -0.41 | 0.48 |
P/S Ratio (TTM) | 6.64 | 18.52 |
P/B Ratio (TTM) | 2.55 | 15.89 |
P/FCF Ratio (TTM) | 63.30 | 41.37 |
Price to 5YR AVG Earnings Ratio | N/A | 75.23 |
Price to 5YR AVG FCF Ratio | N/A | 101.06 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -4.43% | -2.53% |
ROE (TTM) | -6.19% | 9.50% |
Net Profit Margin (TTM) | -15.90% | 4.63% |
ROIC 5YR AVG | N/A | 5.55% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -8.00% | -26.62% | N/A |
Revenue | 5.15% | 3.38% | N/A |
Net Income | -8.43% | -21.29% | N/A |
Cash Flow | 112.10% | 92.34% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.76 | 1.88 |
Quick Ratio (TTM) | 0.76 | 1.87 |
D/E Ratio (TTM) | 0.15 | 0.51 |
Interest Coverage (TTM) | -7.68 | 13.00 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 3.30 | 10.65 |
LTL to 5YR AVG FCF | N/A | 3.98 |
Shares Outstanding Growth 5YR AVG | N/A | 50.77% |